Skip to main content
MedPathMedPath Home
Clinical Trials/ACTRN12611000617965
ACTRN12611000617965
Not yet recruiting
Phase 4

Comparison of two combined oral contraceptive regimens and an intravaginal hormonal ring against placebo for management of bleeding problems in women using Implanon, the sub-dermal contraceptive implant

Dr Edith Weisberg0 sites200 target enrollmentJune 16, 2011
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditionsnacceptable bleeding pattern in women using the progestogen-only sub-dermal contraceptive implantUnacceptable bleeding pattern in women using the progestogen-only sub-dermal contraceptive implantReproductive Health and Childbirth - Contraception

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
nacceptable bleeding pattern in women using the progestogen-only sub-dermal contraceptive implant
Sponsor
Dr Edith Weisberg
Enrollment
200
Status
Not yet recruiting
Last Updated
6 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 16, 2011
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Dr Edith Weisberg

Eligibility Criteria

Inclusion Criteria

  • •\*Implanon users, with a complaint of episodes of prolonged (10 days or greater) or frequent bleeding (more than 4 bleeding episodes in a 90 day reference period).
  • •\*Women who are willing to participate in a research investigation of new approaches for the management of troublesome bleeding.
  • •\*Women who are willing to maintain a 90 day bleeding diary prior to and post treatment initiation.

Exclusion Criteria

  • •Women who have currently or previously had
  • •\*Heart attack or stroke
  • •\*Blood clot in a vein
  • •\*High blood pressure
  • •\*Severe liver or kidney disease
  • •\*Blood pressure \> 135 mm systolic or \>85 mm diastolic
  • •\*Migraine with aura
  • •\*Breast cancer or any genital cancer
  • •\*Severe chronic liver or kidney disease
  • •\*Women with known sensitivity to ethinyl oestradiol, progestogens

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Not Applicable
To compare the effects of two drugs in the management of abnormal uterine bleedingHealth Condition 1: N938- Other specified abnormal uterine and vaginal bleeding
CTRI/2024/07/070066Government Medical College and Hospital Sector Chandigarh India Pincode
Completed
Not Applicable
Comparison of the metabolic and hormonal effects of two oral contraceptives in women with polycystic ovary syndrome (PCOS) for a period of two years follow-up.Polycystic ovary syndromeContraceptionReproductive Health and Childbirth - ContraceptionReproductive Health and Childbirth - Other reproductive health and childbirth disordersMetabolic and Endocrine - Other metabolic disorders
ACTRN12614000722695Recep Yildizhan106
Completed
Phase 3
Comparison of combined oral contraceptive Yasmin and Cyproteron compound on Hirsutism and androgens in women with a polycystic ovary syndromeCondition 1: Polycystic ovarian syndrome. Condition 2: Hirsutism.Polycystic ovarian syndromeHypertrichosis
IRCT201104251760N13Vice Chancellor for Research and Technology, Babol University of Medical Sciences100
Recruiting
Not Applicable
The effectiveness of Combined oral contraceptive pills(COC) in prevention of corpus luteal cyst after oocyte retrieval in in vitro fertilization(IVF) technique, A randomized control trialFemale infertile patientsIn vitro fertilizationCombined oral contraceptive pillsCorpus luteal cystOocyte retrieval
TCTR20190802001Mahidol university130
Not yet recruiting
Phase 4
To compare efficacy and safety of oral contraceptive pill vs pioglitazone in polycystic ovary syndrome (PCOS) women.Health Condition 1: E282- Polycystic ovarian syndrome
CTRI/2020/03/024267SKIMS